Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in Taiwan

Hepatology

Volumn 59, Issue 5, 2014, Pages 1840-1849

  Yeh, Yen Po ^a   Hu, Tsung Hui ^b   Cho, Po Yuan ^c   Chen, Hsiu Hsi ^d   Yen, Amy Ming Fang ^e   Chen, Sam Li Sheng ^e   Chiu, Sherry Yueh Hsia ^f   Fann, Jean Ching Yuan ^g   Su, Wei Wen ^h   Fang, Yi Jen ⁱ   Chen, Shih Tien ^j   San, Hsiao Ching ^a   Chen, Hung Pin ^k   Liao, Chao Sheng ^l,m  

^a Changhua County Public Health Bureau   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c Changhua County Government   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f CHANG GUNG UNIVERSITY   (Taiwan)

^g KAINAN UNIVERSITY   (Taiwan)

^h CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

ⁱ SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^j Chang Hua Hospital   (Taiwan)

^k Changhua County Ershuei Township Health Center Changhua   (Taiwan)

^l SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^m FU JEN CATHOLIC UNIVERSITY   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; RISK; TAIWAN;

EID: 84899476546     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26703     Document Type: Article

References (12)

1. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855-1859.
2. Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol 2012;107:569-577.
3. Tseng PL, Wang JH, Tung HD, Hung CH, Kee KM, Chen CH, et al. Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screening. J Gastroenterol Hepatol 2010;25:1426-1434.
4. Chen TH, Chen CJ, Yen MF, Lu SN, Sun CA, Huang GT, et al. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. Int J Cancer 2002;98:257-261.
5. Chen TH, Chiu YH, Luh DL, Yen MF, Wu HM, Chen LS, et al. Taiwan Community-Based Integrated Screening Group. Community-based multiple screening model: design, implementation, and analysis of 42, 387 participants. Cancer 2004;100:1734-1743.
6. Lai MS, Hsieh MS, Chiu YH, Chen TH. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology 2006;43:1295-1302.
7. Lu SN, Wang JH, Liu SL, Hung CH, Chen CH, Tung HD, et al. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Cancer 2006;107:2212-2222.
8. Chiu YH, Chen LS, Chan CC, Liou DM, Wu SC, Kuo HS, et al. Health information system for community-based multiple screening in Keelung, Taiwan (Keelung Community-based Integrated Screening No. 3). Int J Med Inform 2006;75:369-383.
9. Bruix J, Sherma M. Management of hepatocellular carcinoma: an update. Hepatology 2010;53:1020-1022.
10. Yu EW, Chie WC, Chen THH. Does screening or surveillance for primary hepatocellular carcinoma with ultrasonography improve the prognosis of patients? Cancer J 2004;10:317-325.
11. Fan JG, Zhu J, Li XJ, Chen L, Lu YS, Li L, et al. Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol 2005;20:1825-1832.
12. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;16:1221-1231.